REGIONAL HEALTH AND SOCIAL CARE BOARD

Their core work

The Health and Social Care Board (HSCB) is the public authority responsible for commissioning, planning, and performance-managing health and social care services across Northern Ireland. In the H2020 context, they contributed as a real-world healthcare system actor — bringing clinical service delivery expertise and direct patient population access to research consortia. Their H2020 engagement centred on digital health adoption, specifically mobile-enabled stroke rehabilitation and supporting practitioners and patients in building digital literacy. As a public commissioner rather than a research institution, their core value is translating research outputs into deployable NHS-equivalent services.

What they specialise in

How they've shifted over time

HSCB's H2020 engagement began with a concrete applied health intervention — mobile stroke rehabilitation — with keywords anchored in patient self-care, digital literacy, and safe clinical practice. Their second project, SPARK, shifted toward research capacity building and doctoral knowledge partnerships, suggesting a move from direct clinical technology pilots toward broader research ecosystem involvement. With only two projects and no activity beyond 2017, the picture is too thin to confirm a durable trend, but the trajectory hints at growing interest in connecting the health service with the academic talent pipeline.

HSCB appears to be moving from being an end-user of applied health technology projects toward a broader role as a healthcare system anchor for research consortia seeking real-world implementation environments.

How they like to work

HSCB operates exclusively as a partner or third-party contributor — they have never led an H2020 project. This is consistent with their role as a public health authority: they provide system access, patient populations, and service delivery context rather than scientific leadership. Despite minimal direct funding, they are embedded in relatively large consortia (42 partners across 19 countries), suggesting they are valued for their healthcare system credentials rather than research capacity.

HSCB has engaged with 42 unique consortium partners across 19 countries — a surprisingly broad network for an organisation with only two projects and minimal direct funding. This reflects the large consortium structures typical of MSCA and PCP funding schemes rather than a dense bilateral network.

What sets them apart

HSCB is one of very few public health commissioning bodies from the UK/Northern Ireland that appears in H2020 consortia, giving them a rare position as a representative of the NHS-equivalent system in research partnerships. Unlike universities or research hospitals, they offer something different: the ability to speak for a regional health system and, in principle, to influence the adoption pathway for new technologies. For consortia needing a credible public health end-user from the UK, HSCB fills a niche that academic partners cannot.

Highlights from their portfolio

• MAGIC
  The only directly funded project for HSCB, focused on mobile-assisted stroke rehabilitation — a high-impact clinical use case combining digital health, patient empowerment, and community care delivery.
• SPARK
  An MSCA COFUND doctoral programme spanning 2017-2022, notable for placing HSCB in a research training consortium, signalling the organisation's interest in building long-term academic connections beyond single project cycles.